751.45
price down icon3.25%   -25.27
after-market Handel nachbörslich: 752.80 1.35 +0.18%
loading

Lilly Eli Co Aktie (LLY) Neueste Nachrichten

pulisher
May 08, 2025

Eli Lilly, Novo Nordisk report strong earnings as GLP-1 race heats up - Healthcare Brew

May 08, 2025
pulisher
May 08, 2025

Eli Lilly and Company (LLY) Announces Results of 2025 Annual Sha - GuruFocus

May 08, 2025
pulisher
May 08, 2025

One of the Largest Teacher Pension Funds in the U.S. Sold Nvidia, Tesla, and Apple and Piled Into a Popular Pharmaceutical Stock Up 395% Over the Last 5 Years - The Motley Fool

May 08, 2025
pulisher
May 08, 2025

Eli Lilly & Co Shareholders Vote on Key Issues - TipRanks

May 08, 2025
pulisher
May 08, 2025

Eli Lilly (NYSE:LLY) Announces Executive Changes To Drive Global Growth And Pipeline Advancement - simplywall.st

May 08, 2025
pulisher
May 08, 2025

Top Stock Movers Now: AB InBev, Molson Coors, Eli Lilly, and More - MSN

May 08, 2025
pulisher
May 08, 2025

Lilly shuffles roles amid growth in U.S. investment, diabetes and obesity treatments - Inside INdiana Business

May 08, 2025
pulisher
May 08, 2025

Eli Lilly falls, Arm reacts to chip curbs, D-Wave skyrockets - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Palantir, Eli Lilly lead Thursday’s market cap stock movers By Investing.com - Investing.com Canada

May 08, 2025
pulisher
May 08, 2025

FDA, Eli Lilly Score Win in Weight Loss Drug Shortage Decision - Bloomberg Law News

May 08, 2025
pulisher
May 08, 2025

Eli Lilly (LLY) Restructures Leadership to Propel U.S. Growth - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Are Wall Street Analysts Bullish On Eli Lilly Stock? - Barchart.com

May 08, 2025
pulisher
May 08, 2025

Eli Lilly shifts executive roles to spur growth - Investing.com

May 08, 2025
pulisher
May 08, 2025

Lilly names new executives in leadership transition (LLY:NYSE) - Seeking Alpha

May 08, 2025
pulisher
May 08, 2025

Lilly announces transitions in executive leadership | Eli Lilly and Company - Eli Lilly and Company

May 08, 2025
pulisher
May 08, 2025

Eli Lilly & Co. (LLY) Announces Leaderhsip Changes - StreetInsider

May 08, 2025
pulisher
May 08, 2025

Lilly announces transitions in executive leadership - Stock Titan

May 08, 2025
pulisher
May 08, 2025

After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued? - Morningstar

May 08, 2025
pulisher
May 08, 2025

Down Nearly 20%: Should You Buy the Dip on Eli Lilly? - MSN

May 08, 2025
pulisher
May 08, 2025

'We are all richer for having had him in our lives': Patrick Holden dies after 500 Festival run - IndyStar

May 08, 2025
pulisher
May 07, 2025

FDA Gets Win In Eli Lilly Weight Loss Drug Shortage Fight - Law360

May 07, 2025
pulisher
May 07, 2025

US judge sides with FDA's removal of Lilly's weight loss drug from shortage list - Reuters

May 07, 2025
pulisher
May 07, 2025

Judge Upholds FDA Decision Ending Zepbound Shortage, Favoring Eli Lilly (LLY) - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Lilly benefits as judge upholds FDA removing Zepbound from shortages list - Seeking Alpha

May 07, 2025
pulisher
May 07, 2025

Eli Lilly and Company (LLY): A Bull Case Theory - MSN

May 07, 2025
pulisher
May 07, 2025

Lilly chief scientist talks drugmaker’s new $4.5B campus, recruiting and innovation - Indianapolis Business Journal

May 07, 2025
pulisher
May 07, 2025

Jim Cramer Says Eli Lilly and Company (LLY) CEO David Ricks Is ‘Very Conservative’ - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Construction begins on $4.5 billion Eli Lilly facility in Lebanon - WFYI

May 07, 2025
pulisher
May 07, 2025

Eli Lilly & Co. (LLY) option IV flat - StreetInsider

May 07, 2025
pulisher
May 06, 2025

Lilly breaks ground on $4.5B foundry campus in Lebanon’s LEAP District - Indianapolis Business Journal

May 06, 2025
pulisher
May 06, 2025

Lilly breaks ground on $4.5 billion R&D facility - WISH-TV

May 06, 2025
pulisher
May 06, 2025

Governor breaks ground on $4.5 billion Lilly Medicine Foundry in Lebanon - reporter.net

May 06, 2025
pulisher
May 06, 2025

Eli Lilly Stock Is Sliding Tuesday: What's Going On? - Benzinga

May 06, 2025
pulisher
May 06, 2025

Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped - The Motley Fool

May 06, 2025
pulisher
May 06, 2025

Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership? - Nasdaq

May 06, 2025
pulisher
May 06, 2025

Eli Lilly (LLY) Raises Dividend by 15%, Maintains Shareholder Payout for 55th Consecutive Year - TipRanks

May 06, 2025
pulisher
May 06, 2025

Eli Lilly Stock Plunges: LLY Shares Dive Nearly 3% in Morning Trading - paginasiete.bo

May 06, 2025
pulisher
May 06, 2025

Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip? - The Motley Fool

May 06, 2025
pulisher
May 06, 2025

Eli Lilly (LLY) Partners with Alchemab on ALS Drug Development - GuruFocus

May 06, 2025
pulisher
May 06, 2025

ELI LILLY AND COMPANY (LLY) - MSN

May 06, 2025
pulisher
May 06, 2025

Lilly to Break Ground on $4.5 Billion Medicine Foundry in Lebanon - WIBC

May 06, 2025
pulisher
May 06, 2025

Alchemab Therapeutics signs landmark $415m licensing agreement for ATLX-1282 with Eli Lilly and Company - PrimePublishers.com

May 06, 2025
pulisher
May 05, 2025

Lilly to break ground on $4.5 billion medicine foundry in Lebanon - WISH-TV

May 05, 2025
pulisher
May 05, 2025

Eli Lilly (LLY) Maintains Quarterly Dividend at $1.50 Per Share - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Eli Lilly announces $1.50 Q2 dividend per share By Investing.com - Investing.com India

May 05, 2025
pulisher
May 05, 2025

Eli Lilly announces $1.50 Q2 dividend per share - Investing.com

May 05, 2025
pulisher
May 05, 2025

Lilly declares second-quarter 2025 dividend - Quantisnow

May 05, 2025
pulisher
May 05, 2025

LLY stock news: Eli Lilly Declares $1.50 Quarterly Dividend - paginasiete.bo

May 05, 2025
pulisher
May 05, 2025

Lilly declares second-quarter 2025 dividend | Eli Lilly and Company - Eli Lilly and Company

May 05, 2025
pulisher
May 05, 2025

Eli Lilly & Co. (LLY) Declares $1.50 Quarterly Dividend; 0.7% Yield - StreetInsider

May 05, 2025
pulisher
May 05, 2025

Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know - Yahoo Finance

May 05, 2025
pulisher
May 05, 2025

Eli Lilly’s Strategic Adjustments and Growth Prospects Reinforce Buy Rating Despite Setbacks - TipRanks

May 05, 2025
pulisher
May 04, 2025

Eli Lilly First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo

May 04, 2025
pulisher
May 04, 2025

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash? - AOL.com

May 04, 2025
pulisher
May 03, 2025

This pill could forever change how people lose weight3 May 2025Time Magazine EuropeReadly | All magazines - Readly | All magazines - one magazine app subscription

May 03, 2025
pulisher
May 03, 2025

Eli Lilly and Company (NYSE:LLY) Q1 2025 Earnings Call Transcript - Insider Monkey

May 03, 2025
pulisher
May 02, 2025

Eli Lilly (LLY) Stock Rating Maintained by UBS Despite Price Tar - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Eli Lilly (NYSE:LLY) Announces Promising Trial Data And Updates 2025 Guidance - Yahoo Finance

May 02, 2025
pulisher
May 02, 2025

UBS cuts Eli Lilly stock target to $1,050, maintains Buy rating - Investing.com UK

May 02, 2025
pulisher
May 02, 2025

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday - AOL.com

May 02, 2025
pulisher
May 02, 2025

Eli Lilly’s Stock Selloff Is Overdone, Analysts Say. Here’s Why. - MSN

May 02, 2025
pulisher
May 02, 2025

Cantor Fitzgerald maintains $975 target on Eli Lilly stock By Investing.com - Investing.com India

May 02, 2025
pulisher
May 02, 2025

Cantor Fitzgerald maintains $975 target on Eli Lilly stock - Investing.com

May 02, 2025
pulisher
May 02, 2025

Eli Lilly Stays Strong Despite CVS Dropping Key Drug - Finimize

May 02, 2025
drug_manufacturers_general JNJ
$155.66
price down icon 1.04%
$185.58
price down icon 1.33%
drug_manufacturers_general NVO
$64.85
price down icon 4.00%
drug_manufacturers_general NVS
$110.13
price down icon 1.41%
drug_manufacturers_general MRK
$77.65
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):